May 27, 2021
Iwate Tohoku Medical Megabank Organization, Iwate Medical University
Tohoku Medical Megabank Organization, Tohoku University
Social Life Science, Graduate School of Medical Sciences, Nagoya University
Department of Epidemiology, Center for Public Health Sciences, National Cancer Center
Department of Preventive Medicine and Public Health, Keio University School of Medicine
Division of Cancer Prevention, Research Institute, Aichi Cancer Center
Japan Agency for Medical Research and Development
Six domestic research institutions—the Iwate Tohoku Medical Megabank Organization (IMM) of Iwate Medical University, the Tohoku Medical Megabank Organization (ToMMo) of Tohoku University, the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study for which Nagoya University serves as the administrative office, the Japan Public Health Center-based Prospective (JPHC) Study coordinated by the National Cancer Center, the Tsuruoka Metabolomics Cohort (TMC) Study by Keio University, and the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC2,3)—have established a comprehensive collaborative research framework (Domestic Genome Cohort Collaboration) for the mutual use of information collected in each cohort study. (Agreement concluded on March 5, 2021)
This collaboration will enable the six institutions to sequentially and mutually utilize genome cohort data from 366,000 individuals, promoting genomic epidemiological research such as elucidating the genetic predispositions that influence disease onset in the Japanese population and constructing disease risk prediction models. It is expected to contribute to the early realization of next-generation medicine, including personalized medicine, personalized prevention, and risk prediction tailored to each individual's constitution.
For the full press release, please see below.